Hasil Pencarian - Giorgio Valabrega

Perbaiki Hasil
  1. 1
    Ovarian Cancer Immunotherapy: Turning up the Heat

    Ovarian Cancer Immunotherapy: Turning up the Heat oleh Eleonora Ghisoni, Martina Imbimbo, Stefan Zimmermann, Giorgio Valabrega

    Diterbitkan 2019-06-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  2. 2
    Immune Checkpoint Inhibitors: A New Opportunity in the Treatment of Ovarian Cancer?

    Immune Checkpoint Inhibitors: A New Opportunity in the Treatment of Ovarian Cancer? oleh Gloria Mittica, Sofia Genta, Massimo Aglietta, Giorgio Valabrega

    Diterbitkan 2016-07-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  3. 3
    The Role of PARP Inhibitors in the Ovarian Cancer Microenvironment: Moving Forward From Synthetic Lethality

    The Role of PARP Inhibitors in the Ovarian Cancer Microenvironment: Moving Forward From Synthetic Lethality oleh Margherita Turinetto, Margherita Turinetto, Giulia Scotto, Giulia Scotto, Valentina Tuninetti, Valentina Tuninetti, Gaia Giannone, Gaia Giannone, Giorgio Valabrega, Giorgio Valabrega

    Diterbitkan 2021-06-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  4. 4
    Differences in PARP Inhibitors for the Treatment of Ovarian Cancer: Mechanisms of Action, Pharmacology, Safety, and Efficacy

    Differences in PARP Inhibitors for the Treatment of Ovarian Cancer: Mechanisms of Action, Pharmacology, Safety, and Efficacy oleh Giorgio Valabrega, Giulia Scotto, Valentina Tuninetti, Arianna Pani, Francesco Scaglione

    Diterbitkan 2021-04-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  5. 5
    Immunotherapy for Cervical Cancer: Are We Ready for Prime Time?

    Immunotherapy for Cervical Cancer: Are We Ready for Prime Time? oleh Margherita Turinetto, Anna A. Valsecchi, Valentina Tuninetti, Giulia Scotto, Fulvio Borella, Giorgio Valabrega

    Diterbitkan 2022-03-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  6. 6
    Immune Checkpoint Inhibitors in Epithelial Ovarian Cancer: An Overview on Efficacy and Future Perspectives

    Immune Checkpoint Inhibitors in Epithelial Ovarian Cancer: An Overview on Efficacy and Future Perspectives oleh Fulvio Borella, Eleonora Ghisoni, Gaia Giannone, Stefano Cosma, Chiara Benedetto, Giorgio Valabrega, Dionyssios Katsaros

    Diterbitkan 2020-03-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  7. 7
    Immuno-Metabolism and Microenvironment in Cancer: Key Players for Immunotherapy

    Immuno-Metabolism and Microenvironment in Cancer: Key Players for Immunotherapy oleh Gaia Giannone, Eleonora Ghisoni, Sofia Genta, Giulia Scotto, Valentina Tuninetti, Margherita Turinetto, Giorgio Valabrega

    Diterbitkan 2020-06-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  8. 8
    Role of Cyclin-Dependent Kinase Inhibitors in Endometrial Cancer

    Role of Cyclin-Dependent Kinase Inhibitors in Endometrial Cancer oleh Gaia Giannone, Valentina Tuninetti, Eleonora Ghisoni, Sofia Genta, Giulia Scotto, Gloria Mittica, Giorgio Valabrega

    Diterbitkan 2019-05-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  9. 9
    CAR-Based Strategies beyond T Lymphocytes: Integrative Opportunities for Cancer Adoptive Immunotherapy

    CAR-Based Strategies beyond T Lymphocytes: Integrative Opportunities for Cancer Adoptive Immunotherapy oleh Ramona Rotolo, Valeria Leuci, Chiara Donini, Anna Cykowska, Loretta Gammaitoni, Giovanni Medico, Giorgio Valabrega, Massimo Aglietta, Dario Sangiolo

    Diterbitkan 2019-06-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  10. 10
    Biomarkers of Central Nervous System Involvement from Epithelial Ovarian Cancer

    Biomarkers of Central Nervous System Involvement from Epithelial Ovarian Cancer oleh Giulia Scotto, Fulvio Borella, Margherita Turinetto, Valentina Tuninetti, Anna A. Valsecchi, Gaia Giannone, Stefano Cosma, Chiara Benedetto, Giorgio Valabrega

    Diterbitkan 2021-12-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  11. 11
    Ovarian Cancer Cells in Ascites Form Aggregates That Display a Hybrid Epithelial-Mesenchymal Phenotype and Allows Survival and Proliferation of Metastasizing Cells

    Ovarian Cancer Cells in Ascites Form Aggregates That Display a Hybrid Epithelial-Mesenchymal Phenotype and Allows Survival and Proliferation of Metastasizing Cells oleh Sonia Capellero, Jessica Erriquez, Chiara Battistini, Roberta Porporato, Giulia Scotto, Fulvio Borella, Maria F. Di Renzo, Giorgio Valabrega, Martina Olivero

    Diterbitkan 2022-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  12. 12
    Cancer Cells Haploinsufficient for ATM Are Sensitized to PARP Inhibitors by <i>MET</i> Inhibition

    Cancer Cells Haploinsufficient for ATM Are Sensitized to PARP Inhibitors by <i>MET</i> Inhibition oleh Concetta D’Ambrosio, Jessica Erriquez, Sonia Capellero, Simona Cignetto, Maria Alvaro, Eric Ciamporcero, Maria Flavia Di Renzo, Timothy Perera, Giorgio Valabrega, Martina Olivero

    Diterbitkan 2022-05-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  13. 13
    Management of Metastatic Endometrial Cancer: Physicians’ Choices Beyond the First Line. A MITO Survey

    Management of Metastatic Endometrial Cancer: Physicians’ Choices Beyond the First Line. A MITO Survey oleh Gaia Giannone, Gaia Giannone, Gaia Giannone, Daniele Castaldo, Valentina Tuninetti, Valentina Tuninetti, Giulia Scotto, Giulia Scotto, Margherita Turinetto, Margherita Turinetto, Anna Amela Valsecchi, Anna Amela Valsecchi, Michele Bartoletti, Serafina Mammoliti, Grazia Artioli, Giorgia Mangili, Vanda Salutari, Domenica Lorusso, Gennaro Cormio, Claudio Zamagni, Antonella Savarese, Massimo Di Maio, Graziana Ronzino, Carmela Pisano, Sandro Pignata, Giorgio Valabrega, Giorgio Valabrega

    Diterbitkan 2022-05-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  14. 14
    TOP2A as marker of response to pegylated lyposomal doxorubicin (PLD) in epithelial ovarian cancers

    TOP2A as marker of response to pegylated lyposomal doxorubicin (PLD) in epithelial ovarian cancers oleh Eleonora Ghisoni, Furio Maggiorotto, Fulvio Borella, Gloria Mittica, Sofia Genta, Gaia Giannone, Dionyssios Katsaros, Alberto Sciarrillo, Annamaria Ferrero, Ivana Sarotto, Jessica Erriquez, Maria Flavia Di Renzo, Massimo Aglietta, Giorgio Valabrega

    Diterbitkan 2019-02-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  15. 15
    A predictive score for optimal cytoreduction at interval debulking surgery in epithelial ovarian cancer: a two- centers experience

    A predictive score for optimal cytoreduction at interval debulking surgery in epithelial ovarian cancer: a two- centers experience oleh Eleonora Ghisoni, Dionyssios Katsaros, Furio Maggiorotto, Massimo Aglietta, Marco Vaira, Michele De Simone, Gloria Mittica, Gaia Giannone, Manuela Robella, Sofia Genta, Fabiola Lucchino, Francesco Marocco, Fulvio Borella, Giorgio Valabrega, Riccardo Ponzone

    Diterbitkan 2018-05-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  16. 16
    From Uterus to Brain: An Update on Epidemiology, Clinical Features, and Treatment of Brain Metastases From Gestational Trophoblastic Neoplasia

    From Uterus to Brain: An Update on Epidemiology, Clinical Features, and Treatment of Brain Metastases From Gestational Trophoblastic Neoplasia oleh Fulvio Borella, Fulvio Borella, Stefano Cosma, Stefano Cosma, Domenico Ferraioli, Mario Preti, Mario Preti, Niccolò Gallio, Niccolò Gallio, Giorgio Valabrega, Giulia Scotto, Alessandro Rolfo, Isabella Castellano, Paola Cassoni, Luca Bertero, Chiara Benedetto, Chiara Benedetto

    Diterbitkan 2022-04-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  17. 17
    Corrigendum: Optimizing the use of lenvatinib in combination with pembrolizumab in patients with advanced endometrial carcinoma

    Corrigendum: Optimizing the use of lenvatinib in combination with pembrolizumab in patients with advanced endometrial carcinoma oleh Domenica Lorusso, Domenica Lorusso, Romano Danesi, Laura Deborah Locati, Laura Deborah Locati, Gianluca Masi, Gianluca Masi, Ugo De Giorgi, Angiolo Gadducci, Sandro Pignata, Roberto Sabbatini, Antonella Savarese, Giorgio Valabrega, Claudio Zamagni, Nicoletta Colombo, Nicoletta Colombo

    Diterbitkan 2023-08-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  18. 18
    Optimizing the use of lenvatinib in combination with pembrolizumab in patients with advanced endometrial carcinoma

    Optimizing the use of lenvatinib in combination with pembrolizumab in patients with advanced endometrial carcinoma oleh Domenica Lorusso, Domenica Lorusso, Romano Danesi, Laura Deborah Locati, Laura Deborah Locati, Gianluca Masi, Gianluca Masi, Ugo De Giorgi, Angiolo Gadducci, Sandro Pignata, Roberto Sabbatini, Antonella Savarese, Giorgio Valabrega, Claudio Zamagni, Nicoletta Colombo, Nicoletta Colombo

    Diterbitkan 2022-09-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  19. 19
    Validation of Androgen Receptor loss as a risk factor for the development of brain metastases from ovarian cancers

    Validation of Androgen Receptor loss as a risk factor for the development of brain metastases from ovarian cancers oleh Gloria Mittica, Margherita Goia, Angela Gambino, Giulia Scotto, Mattia Fonte, Rebecca Senetta, Massimo Aglietta, Fulvio Borella, Anna Sapino, Dionyssios Katsaros, Furio Maggiorotto, Eleonora Ghisoni, Gaia Giannone, Valentina Tuninetti, Sofia Genta, Chiara Eusebi, Marina Momi, Paola Cassoni, Giorgio Valabrega

    Diterbitkan 2020-05-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  20. 20
    Corrigendum: Management of metastatic endometrial cancer: physicians’ choices beyond the first line after approval of checkpoint inhibitors

    Corrigendum: Management of metastatic endometrial cancer: physicians’ choices beyond the first line after approval of checkpoint inhibitors oleh Francesca Arezzo, Francesca Arezzo, Gaia Giannone, Daniele Castaldo, Giulia Scotto, Valentina Tuninetti, Margherita Turinetto, Michele Bartoletti, Serafina Mammoliti, Grazia Artioli, Giorgia Mangili, Vanda Salutari, Domenica Lorusso, Gennaro Cormio, Gennaro Cormio, Vera Loizzi, Vera Loizzi, Claudio Zamagni, Antonella Savarese, Massimo Di Maio, Graziana Ronzino, Carmela Pisano, Sandro Pignata, Giorgio Valabrega

    Diterbitkan 2024-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:

Alat Pencarian: